Apyx Medical Corp. (APYX)
2.92
+0.13
(+4.66%)
USD |
NASDAQ |
May 06, 16:00
3.23
+0.31
(+10.62%)
Pre-Market: 08:26
Apyx Medical Cash from Investing (Quarterly) : -0.275M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LeMaitre Vascular, Inc. | -13.12M |
| Abbott Laboratories | -20.32B |
| Accuray, Inc. | -5.596M |
| Alphatec Holdings, Inc. | -19.89M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.53M |
| Cash from Financing (Quarterly) | 9.485M |
| Free Cash Flow | -9.115M |
| Free Cash Flow Per Share (Quarterly) | -0.0665 |
| Free Cash Flow to Equity (Quarterly) | -2.933M |
| Free Cash Flow to Firm (Quarterly) | -1.283M |
| Free Cash Flow Yield | -7.60% |